Guohong Han
Northwest University(CN)National Clinical Research Center for Digestive Diseases(CN)Medical Center Hospital(US)Xi’an International University(CN)Xinxiang Central Hospital(CN)Xijing Hospital(CN)Hubei Cancer Hospital(CN)Xinxiang Medical University(CN)Air Force Medical University(CN)
Publications by Year
Research Areas
Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment, Hepatocellular Carcinoma Treatment and Prognosis, Organ Transplantation Techniques and Outcomes, Hepatitis Viruses Studies and Epidemiology
Most-Cited Works
- → Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial(2018)5,305 cited
- → Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial(2016)3,612 cited
- → Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)(2020)818 cited
- → Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial(2016)685 cited
- → The role of hepatic resection in the treatment of hepatocellular cancer(2015)407 cited
- → Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)(2023)404 cited